Related references
Note: Only part of the references are listed.miR-17 inhibitor suppressed osteosarcoma tumor growth and metastasis via increasing PTEN expression
Yong Gao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer
Nicola Valeri et al.
CANCER CELL (2014)
MicroRNA-492 expression promotes the progression of hepatic cancer by targeting PTEN
Jianxin Jiang et al.
CANCER CELL INTERNATIONAL (2014)
MiR-136 modulates glioma cell sensitivity to temozolomide by targeting astrocyte elevated gene-1
Hao Wu et al.
DIAGNOSTIC PATHOLOGY (2014)
miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer
Yougang Feng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
被撤回的出版物: MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN (Retracted article. See April, 2017)
Lei Shen et al.
TUMOR BIOLOGY (2014)
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
Paula Codo et al.
ONCOTARGET (2014)
MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN)
Weidong Zhou et al.
CELL AND BIOSCIENCE (2014)
Potential Targets for Prevention of Colorectal Cancer: a Focus on PI3K/Akt/mTOR and Wnt Pathways
Ashok Kumar Pandurangan
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
MiR-92b regulates the cell growth, cisplatin chemosensitivity of A549 non small cell lung cancer cell line and target PTEN
Yan Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas
Zhe Bao Wu et al.
BRAIN RESEARCH (2013)
MicroRNA-218 Inhibits Glioma Invasion, Migration, Proliferation, and Cancer Stem-like Cell Self-Renewal by Targeting the Polycomb Group Gene Bmi1
Yanyang Tu et al.
CANCER RESEARCH (2013)
The miR-223/Nuclear Factor I-A Axis Regulates Glial Precursor Proliferation and Tumorigenesis in the CNS
Stacey M. Glasgow et al.
JOURNAL OF NEUROSCIENCE (2013)
MiR-92b inhibitor promoted glioma cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathway
Qifeng Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase
Kun Wang et al.
NEURO-ONCOLOGY (2013)
MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell
Zhu Jianwei et al.
TUMOR BIOLOGY (2013)
Recent Advances in Therapy for Glioblastoma
Jennifer Clarke et al.
ARCHIVES OF NEUROLOGY (2010)
MiR-92b and miR-9/9*Are Specifically Expressed in Brain Primary Tumors and Can Be Used to Differentiate Primary from Metastatic Brain Tumors
Dvora Nass et al.
BRAIN PATHOLOGY (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Tumor initiating cells in malignant gliomas: biology and implications for therapy
Costas G. Hadjipanayis et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
PTEN signaling in brain: neuropathology and tumorigenesis
R. Endersby et al.
ONCOGENE (2008)
The protein kinase Cβ-selective inhibitor, enzastaurin (LY317615.HCI), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts
JR Graff et al.
CANCER RESEARCH (2005)
In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin
M Tanaka et al.
GENE THERAPY (2003)
Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas
K Kurose et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)